Similar articles

• Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?

  Kortylewski M, Nechaev S. Kortylewski M, et al. Ther Deliv. 2014 Mar;5(3):239-42. doi: 10.4155/tde.13.152. Ther Deliv. 2014. PMID: 24592948 No abstract available.
• Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.

  Minakuchi Y, Takeshita F, Kosaka N, Sasaki H, Yamamoto Y, Kouno M, Honma K, Nagahara S, Hanai K, Sano A, Kato T, Terada M, Ochiya T. Minakuchi Y, et al. Nucleic Acids Res. 2004 Jul 22;32(13):e109. doi: 10.1093/nar/gnh093. Nucleic Acids Res. 2004. PMID: 15272050 Free PMC article.
• Nanoparticle-siRNA: A potential cancer therapy?

  Young SW, Stenzel M, Yang JL. Young SW, et al. Crit Rev Oncol Hematol. 2016 Feb;98:159-69. doi: 10.1016/j.critrevonc.2015.10.015. Epub 2015 Oct 31. Crit Rev Oncol Hematol. 2016. PMID: 26597018 Review.
• Noncoding RNA for Cancer Gene Therapy.

  Zhong X, Zhang D, Xiong M, Zhang L. Zhong X, et al. Recent Results Cancer Res. 2016;209:51-60. doi: 10.1007/978-3-319-42934-2_4. Recent Results Cancer Res. 2016. PMID: 28101687 Free PMC article. Review.
• Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

  Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K, Teratani T, Namatame N, Yamamoto Y, Hanai K, Kato T, Sano A, Ochiya T. Takeshita F, et al. Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12177-82. doi: 10.1073/pnas.0501753102. Epub 2005 Aug 9. Proc Natl Acad Sci U S A. 2005. PMID: 16091473 Free PMC article.